Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity.
Emil RydellLennart T H JacobssonTore SaxneCarl TuressonPublished in: BMC rheumatology (2023)
COMP may be a novel predictor of CVD and CAD in RA. Active disease two years after RA diagnosis, as well as cumulative disease activity, was associated with increased risk of CVD and CAD, independent of traditional CVD risk factors. Awareness of the particularly increased CVD risk among difficult to treat patients is important in order to further reduce CVD in RA.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- rheumatoid arthritis patients
- ankylosing spondylitis
- cardiovascular disease
- juvenile idiopathic arthritis
- risk factors
- coronary artery disease
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- interstitial lung disease
- type diabetes
- prognostic factors
- amino acid
- extracellular matrix
- cardiovascular events
- protein protein
- metabolic syndrome